BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30185039)

  • 1. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanomedicine platforms for cancer therapy.
    Zhang H
    J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
    Rehan F; Zhang M; Fang J; Greish K
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
    Muthu MS; Mei L; Feng SS
    Nanomedicine (Lond); 2014 Jul; 9(9):1277-80. PubMed ID: 25204816
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.
    Ranganathan R; Madanmohan S; Kesavan A; Baskar G; Krishnamoorthy YR; Santosham R; Ponraju D; Rayala SK; Venkatraman G
    Int J Nanomedicine; 2012; 7():1043-60. PubMed ID: 22403487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural resources for sustainable synthesis of nanomaterials with anticancer applications: A move toward green nanomedicine.
    Rabiee N; Ahmadi S; Iravani S; Varma RS
    Environ Res; 2023 Jan; 216(Pt 4):114803. PubMed ID: 36379236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy.
    Liu J; Dong J; Zhang T; Peng Q
    J Control Release; 2018 Sep; 286():64-73. PubMed ID: 30031155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swiss National Research Programme "Opportunities and Risks of Nanomaterials" (NRP 64): key findings.
    Aebi U; Gehr P
    J Nanobiotechnology; 2017 Jun; 15(1):47. PubMed ID: 28645282
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody-targeted nanoparticles for cancer therapy.
    Fay F; Scott CJ
    Immunotherapy; 2011 Mar; 3(3):381-94. PubMed ID: 21395380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology in Drug Delivery: Safety and Toxicity Issues.
    Jain K; Mehra NK; Jain NK
    Curr Pharm Des; 2015; 21(29):4252-61. PubMed ID: 26323425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.
    Seth A; Oh DB; Lim YT
    Nanomedicine (Lond); 2015; 10(6):959-75. PubMed ID: 25867860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.